One step at a time: use of single-session rTMS to test novel targets for substance use disorders
Neuropsychopharmacology - One step at a time: use of single-session rTMS to test novel targets for substance use disorders
This recent Research Highlight from @heatherwardmd.bsky.social⬠discusses how single rTMS sessions with fMRI to probe mechanism are critical stepping stones that line the path toward highly effective neuromodulation interventions for substance use
www.nature.com/artic...
16.07.2025 18:27 β
π 5
π 3
π¬ 0
π 0
8. These results have dramatic implications for treatment of psychomotor function in psychotic disorders, as they suggest a unifying role of DMN connectivity in psychomotor disturbance π, overall function, and well-being π.
14.07.2025 18:46 β
π 0
π 0
π¬ 1
π 0
7. We identified significant relationships between the same brain regions and their connectivity patterns to the DMN that were related to well-being π, overall function, and grip strength πͺ.
14.07.2025 18:46 β
π 0
π 0
π¬ 1
π 0
6. Higher grip strength πͺ was correlated with greater connectivity from multiple brain regions to the DMN. Given associations between grip strength and well-being, we repeated this analysis to see if we would identify similar brain correlates for grip and well-being β and we did.
14.07.2025 18:46 β
π 0
π 0
π¬ 1
π 0
5. Using data from the multi-site Human Connectome Project for Early Psychosis (HCP-EP, n=206), we performed a multivariate pattern analysis of the entire connectome π§ to identify brain circuits linked to grip strength πͺ, overall function, and well-being π.
14.07.2025 18:46 β
π 0
π 0
π¬ 1
π 0
4. The brain π§ correlates of grip strength have been presumed to lie in the motor system, so previous brain analyses are frequently restricted to motor regions. However, a unifying brain circuit explanation linking grip strength and overall well-being has remained elusive π until now
14.07.2025 18:46 β
π 0
π 0
π¬ 1
π 0
3. Grip strength ποΈ is one measure of motor function associated with all-cause mortality and overall well-being. It has been assumed that associations between grip strength and well-being are purely related to mechanical impairments reflective of overall poorer physical health.
14.07.2025 18:46 β
π 0
π 0
π¬ 1
π 0
2. Psychomotor disturbance is highly prevalent across psychiatric disorders and has many manifestations, e.g., catatonia, psychomotor retardation, psychomotor agitation, etc. But what is the neurobiological mechanism of psychomotor disturbance π in psychiatric disorders?
14.07.2025 18:46 β
π 0
π 0
π¬ 1
π 0
7. TMS is an exciting intervention for SUDs because of the flexibility in its administration schedule. We should design and test alternative TMS dosing schedules that are: 1) Highly effective πͺ and 2) Accessible for individuals recovering from SUDs.
25.06.2025 14:35 β
π 0
π 0
π¬ 0
π 0
6. Extended dosing: Recovery from substance use takes time and behavior change, and symptoms of post-acute withdrawal can persist for weeks. Extended TMS dosing, such as multiple sessions/day once per week, may be an opportunity to provide continued treatment & relapse prevention
25.06.2025 14:35 β
π 0
π 0
π¬ 1
π 0
5. Accelerated dosing: Newer, accelerated protocols apply multiple TMS sessions per day to shorten time to response. However, protocols that involve treatment for 10h/day x 5 days pose challenges to recovery goals, such as full-time employment, education, or caretaking.
25.06.2025 14:35 β
π 0
π 0
π¬ 1
π 0
4. Flexible dosing: Traditional TMS protocols involve weekly treatment for weeks at a time. Recently, studies have tested flexible protocols that provide TMS a few times/week, allowing for more scheduling flexibility (Meredith Addicott & Greg Sahlem)
25.06.2025 14:35 β
π 0
π 0
π¬ 1
π 0
3. As TMS has been increasingly studied as a novel intervention for SUDs, the principle of patient-centered care has been absent from protocol design. We focus on dosing schedule and advocate for patient-centered neuromodulation protocols to support recovery from SUDs.
25.06.2025 14:35 β
π 0
π 0
π¬ 1
π 0
2. TMS has growing interest and evidence as a novel treatment for substance use disorders (SUDs). Substance use treatment has embraced patient-centered care approaches that prioritize a patientβs individual needs, goals, and treatment preferences.
25.06.2025 14:35 β
π 0
π 0
π¬ 1
π 0
1. Excited to share βRewiring recovery: Patient-centered π§²π§ neuromodulation interventions for substance use disorders that meet people where they are,β in Transcranial Magnetic Stimulation with @VUMCPsych collaborators Sophia Blyth and Kristopher Kast www.sciencedirect.com/science/arti...
25.06.2025 14:35 β
π 1
π 0
π¬ 1
π 0
One step at a time: use of single-session rTMS to test novel targets for substance use disorders - Neuropsychopharmacology
Neuropsychopharmacology - One step at a time: use of single-session rTMS to test novel targets for substance use disorders
Studies like Petersen et al. that use single rTMS sessions with fMRI to probe the mechanism of rTMS for substance use disorders are critical stepping stones toward highly effective neuromodulation interventions for substance use
@heatherwardmd.bsky.social
www.nature.com/articles/s41...
17.06.2025 15:04 β
π 3
π 2
π¬ 1
π 0
These labor-intensive, mechanistic TMS studies are ποΈββοΈ challenging to conduct but provide critical stepping stones for future TMS clinical trials.
16.06.2025 20:37 β
π 1
π 0
π¬ 0
π 0
Only if itβs a randomized, crossover, within-subjects design π€£
10.06.2025 02:17 β
π 0
π 0
π¬ 0
π 0
Congratulations!!!π
10.06.2025 02:16 β
π 1
π 0
π¬ 0
π 0
RePORT β© RePORTER
Excited to announce award of my K99/R00 "Theta burst modulation of hippocampal-cortical rhythms in schizophrenia," under amazing mentors at Stanford including @coreykeller.bsky.social! We will ask whether hippocampal oscillations can be systematically influenced by stimulation in schizophrenia.
09.06.2025 18:49 β
π 22
π 2
π¬ 5
π 1
7. This project would not have been possible without a π€©fantastic team. This analysis was led by @vanderbilt.edu undergrad Daniel Bello (now with @crodriguezmdphd.bsky.social) and grad student Megan Jones @vandyatvandy.bsky.social, @roscoebrady.bsky.social, Sophia Blyth, Ishaan Gadiyar, Laura Artim
09.06.2025 12:45 β
π 2
π 0
π¬ 1
π 0
6. Our analysis suggests that symptom provocation may improve clinical response to TMS for nicotine use and OCD. Large, randomized, controlled trials that directly compare TMS with and without provocation are critical to establish effect of symptom provocation on TMS response.
09.06.2025 12:45 β
π 1
π 0
π¬ 1
π 0
5. We then investigated the individual effect of provocation. Although we did not observe a significant association of provocation with better response to TMS, there were stronger effect sizes of TMS with provocation compared to TMS without provocation for nicotine use and OCD.
09.06.2025 12:45 β
π 1
π 0
π¬ 1
π 0
4. In our analysis, we found 1) Active TMS was more effective than sham for both OCD and nicotine dependence; 2) When comparing active and sham TMS, we observed significant effects of active TMS with or without provocation for OCD and with provocation for nicotine use over sham.
09.06.2025 12:45 β
π 1
π 0
π¬ 1
π 0
3. Single TMS studies have suggested that provoking symptoms may improve TMS response, but this question has never been analyzed in sufficient numbers. We performed a meta-analysis to determine if symptom provocation substantially improved clinical response to TMS.
09.06.2025 12:45 β
π 1
π 0
π¬ 1
π 0